GO
Loading...

Teva Scoops Up Barr

Friday, 18 Jul 2008 | 1:06 PM ET

Generic drug giant Teva Pharmaceuticals bought rival Barr for $7 billion, and some analysts say this could spark a big wave of consolidation. CNBC's Mike Huckman has the details.